| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UKNOWN |
| UNII: | PQP8VH3MJW |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Tumor necrosis factor ligand superfamily member 13B inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lupus Erythematosus, Systemic | 3 | D008180 | ClinicalTrials |
| Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
| Multiple Sclerosis, Relapsing-Remitting | 2 | D020529 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1743075 |
| FDA SRS | PQP8VH3MJW |
CONTENTS